Pivotal bioVenture Partners Fund I, L.P. - Insider Trading & Ownership

Location
501 Second Street, Suite 200, San Francisco, CA
Summary
The estimated value of insider holdings of Pivotal bioVenture Partners Fund I, L.P. is at least $5.61M dollars as of November 12, 2025. Pivotal bioVenture Partners Fund I, L.P. is the Director of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $5.61M.
Signature
/s/ Robert Hopfner - for Pivotal bioVenture Partners Fund I, L.P., By: Robert Hopfner, Managing Partner
All Insider Reports
All Insider Reports

Ownership of Pivotal bioVenture Partners Fund I, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INZY Inozyme Pharma, Inc. Director $5.61M Aug 1, 2023
EVMN Evommune, Inc. Director, 10%+ Owner Nov 7, 2025

Insider Transactions Reported by Pivotal bioVenture Partners Fund I, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.